Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT) System in Advanced Breast Cancer

NCT03202446 is registered in ClinicalTrials.gov with Eske Corporation S.A.C as lead sponsor.

NCT NCT03202446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03202446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT) System in Advanced Breast Cancer
Lead sponsor
Eske Corporation S.A.C
Phase
Phase 3
Overall status
Terminated
Start date
June 13, 2016
Completion date
January 31, 2018
Enrollment
18 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer stage iiia, breast cancer stage iv, breast cancer, stage iiib